Keltie competitive analysis

Explore patent oppositions filed by Keltie against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition Date
Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPEMay 19, 2026
Salt Of A Pyrimido[6,1-A]Isoquinolin-4-One CompoundVERONA PHARMADec 19, 2025
A Packaging ItemNOTPLAAug 26, 2025
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025
Electronic Breath Actuated In-Line Droplet Delivery Device And Methods Of UsePNEUMA RESPIRATORYFeb 21, 2025
Delivery Of Low Surface Tension Compositions To The Pulmonary System Via Electronic Breath Actuated Droplet Delivery DevicePNEUMA RESPIRATORYFeb 21, 2025
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZEROct 31, 2024
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
Automated Cutting Height SystemCLAAS SELBSTFAHRENDE ERNTEMASCHINENSep 9, 2021
Intelligent Controller And Method For Electronic CigaretteJOYETECH CHANGZHOU ELECTRONICSSep 2, 2021

Latest PTAB cases involving Keltie

Discover the latest PTAB cases involving Keltie, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Keltie with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 16, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KELTIE27 - - -
JOYETECH CHANGZHOU ELECTRONICS - 8 - -
PFIZER54984412
PNEUMA RESPIRATORY - 2 - -